US Patent Issued to GI INNOVATION on Sept. 16 for "Fusion protein comprising anti-CD73 antibody and IL-2, and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,984, issued on Sept. 16, was assigned to GI INNOVATION INC. (Seoul, South Korea).

"Fusion protein comprising anti-CD73 antibody and IL-2, and use thereof" was invented by Myung Ho Jang (Seoul, South Korea), Young Jun Koh (Seoul, South Korea) and Dan Bee Ha (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A fusion protein in which an anti-CD73 antibody or an antigen-binding fragment thereof and IL-2 are linked to each other, and the use thereof are disclosed. The fusion protein or dimer thereof contains an anti-CD73 antibody or an antigen-binding fragment thereof and IL-2, and is able to inhibit adenosine production by binding to C...